Trademark Search  /  FRXDI FORUM FOR GLOBAL PHARMACEUTICAL DIVERSITY AND INCLUSION

FRXDI FORUM FOR GLOBAL PHARMACEUTICAL DIVERSITY AND INCLUSION

○ Dead · Abandoned

U.S. federal trademark · Serial No. 77326262

Mark
FRXDI FORUM FOR GLOBAL PHARMACEUTICAL DIVERSITY AND INCLUSION
Status
Abandoned
Serial Number
77326262
Filing Date
November 9, 2007
Class(es)
Class 035, Class 036, Class 041

Owners

Forum for Global Pharmaceutical Diversity and Inclusion, Inc.
99 · Beverly Hills, CA, US
Forum for Global Pharmaceutical Diversity and Inclusion, Inc.
99 · Beverly Hills, CA, US

Goods & Services

Promoting public awareness of the need for career growth for diversity and minority individuals in the pharmaceutical and healthcare industries; promoting public awareness of enrolling diversity students in the pharmaceutical education programs of others and in promoting public awareness in diversity career advancement and leadership in the pharmaceutical industry; human resource consulting services in the field of diversity human resource development in the pharmaceutical industry

Education services, namely, providing classes, seminars and workshops for the public and pharmaceutical and healthcare communities in the field of values and benefits of diverse cultural and ethnic participation; Education services, namely, providing classes, seminars and workshops in the field of diversity employment in the pharmaceutical and healthcare industries; conducting awards programs for individuals and corporations who have made significant charitable contributions benefiting minority populations in the pharmaceutical industry

Charitable fund raising targeted toward diversity employment in the pharmaceutical and healthcare industries

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "FRXDI FORUM FOR GLOBAL PHARMACEUTICAL DIVERSITY AND INCLUSION" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.